Senior insider sale
See Remarks at CANDEL THERAPEUTICS, INC. — senior position signals high conviction
$68.5K
7K shares
What this filing means
TYAGARAJAN SESHU plans to sell 7K shares of CANDEL THERAPEUTICS, INC. valued at approximately $68.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/29/2026ACC: 0001950047-26-006607
Officer· See Remarks
Since Apr 2022
7K
Shares to sell
$68.5K
Approx. market value
7K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
1/7/2025
7KTotal acquired7K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/7/2025 | Restricted Stock Units N/A | 7K | — |
| Total | 7K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
7K
Market value
$68.5K
6/29/2026
Total
Units
7K
Value
$68.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/29/2026 | 7K | $68.5K | NASDAQ | Planned |
| Total | 7K | $68.5K | ||